Kim Do-Hyoung, Kim Hong-Bae, Kim Young-Hyo, Kim Ja-Young
Department of Family Medicine, MyongJi Hospital, Goyang, Korea.
Department of Family Medicine, Yonsei University College of Medicine, Seoul, Korea.
Korean J Fam Med. 2018 Jul;39(4):211-218. doi: 10.4082/kjfm.17.0025. Epub 2018 Jul 5.
Previous observational epidemiological studies have shown inconsistent results on the relationship between hypnotics use and risk of cancer. To determine the association between hypnotics use and risk of cancer, we conducted a meta-analysis of available literature.
We searched databases PubMed, EMBASE, and the bibliographies of relevant articles to locate additional publications in February 2016. Three evaluators independently reviewed and selected eligible studies based on pre-determined selection criteria.
A total of six observational epidemiological studies including three case-control studies and three cohort studies, which involved 1,830,434 participants (202,629 hypnotics users and 1,627,805 non-users), were included in the final analyses. In a random-effects meta-analysis, compared with non-use of hypnotics, the odds ratio for overall hypnotics use was 1.29 for various cancers (95% confidence interval, 1.08-1.53). Subgroup meta-analyses by various factors such as study design, type of case-control study, study region, and methodological quality of study revealed consistent findings.
Our findings from a meta-analysis of low-biased epidemiological studies suggested evidence linking the use of hypnotics to an increased risk of cancers. The results should be cautiously interpreted because of considerable heterogeneity with a high I square value.
既往观察性流行病学研究显示,催眠药物使用与癌症风险之间的关系结果不一致。为确定催眠药物使用与癌症风险之间的关联,我们对现有文献进行了一项荟萃分析。
我们检索了PubMed、EMBASE数据库以及相关文章的参考文献,以查找2016年2月的其他出版物。三名评估人员根据预先确定的选择标准独立审查并选择符合条件的研究。
最终分析纳入了总共六项观察性流行病学研究,包括三项病例对照研究和三项队列研究,涉及1,830,434名参与者(202,629名催眠药物使用者和1,627,805名非使用者)。在随机效应荟萃分析中,与不使用催眠药物相比,各种癌症总体使用催眠药物的比值比为1.29(95%置信区间,1.08 - 1.53)。按研究设计、病例对照研究类型、研究地区和研究方法质量等各种因素进行的亚组荟萃分析显示了一致的结果。
我们对低偏倚流行病学研究的荟萃分析结果表明,有证据表明使用催眠药物会增加患癌风险。由于异质性相当大且I²值较高,这些结果应谨慎解读。